中文 | ENGLISH

- ABOUT US -

Expected to reach RMB 8 trillion in 2020, the healthcare industry in China is one of the largest and the fastest growing in the world. What’s more, it is undergoing significant structural changes. Headquartered in Shanghai, Cenova Capital is one of the earliest investors that are dedicated to early and growth-stage investment in the life science and healthcare in China. With the much coveted QFLP, Cenova enables the immediate conversion of foreign investment into local currency for direct investment into Chinese companies.

Leveraging its core team’s rich China-operational experiences, international resources and business acumen, Cenova has made thoughtful investment into a plethora of sub-sector leaders in its focus areas, including healthcare services, diagnostics, medical devices, and pharmaceuticals. With connected capitals and unique value-adds, Cenova is in a position unlike any other venture firm to take advantages of the great opportunities unleashed by the China healthcare transformation process.